Applied Lipid Technologies
Tracked across 2 events · 14 articles · First seen Apr 11, 2026 · Last active Aug 20, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Applied Lipid Technologies, a wholly owned subsidiary of Lobe Sciences, will receive a portion of the private placement proceeds to support the development of the S-100 program toward human clinical trials.
Apr 11, 2026 · 7 articles
Business
Impact: Applied Lipid Technologies, a wholly owned subsidiary, will receive a portion of the proceeds to advance the S-100 program toward human clinical trials. The funding supports its lead asset for sickle cell disease.
Aug 12, 2026 · 7 articles
ERGEN INTELLIGENCE
Track Applied Lipid Technologies live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard